{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:19:14Z","timestamp":1790716754747,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.pharmthera.2015.12.002","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T15:40:06Z","timestamp":1450453206000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Developing natural product drugs: Supply problems and how they have been overcome"],"prefix":"10.1016","volume":"162","author":[{"given":"David J.","family":"Newman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2015.12.002_bb0005","doi-asserted-by":"crossref","first-page":"e97257","DOI":"10.1371\/journal.pone.0097257","article-title":"Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo Infection and activation of viral LTR","volume":"9","author":"Abreu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0010","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1021\/ja00034a086","article-title":"Total synthesis of halichondrin B and norhalichondrin B","volume":"114","author":"Aicher","year":"1992","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/np980218n","article-title":"An expeditious procedure for the isolation of ingenol from the seeds of Euphorbia lathyris","volume":"62","author":"Appendino","year":"1999","journal-title":"J Nat Prod"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0032-1317920","article-title":"Process development of Halaven\u00ae: Synthesis of the C14\u2013C35 fragment via iterative Nozaki\u2013Hiyama\u2013Kishi reaction-Williamson ether cyclization","volume":"24","author":"Austad","year":"2013","journal-title":"Synlett"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0032-1318026","article-title":"Commercial manufacture of Halaven\u00ae: chemoselective transformations en route to structurally complex macrocyclic ketones","volume":"24","author":"Austad","year":"2013","journal-title":"Synlett"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/leu.2013.249","article-title":"Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphoma","volume":"28","author":"Axelrod","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0035","doi-asserted-by":"crossref","first-page":"15882","DOI":"10.1016\/S0021-9258(18)98491-7","article-title":"Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data","volume":"266","author":"Bai","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0040","doi-asserted-by":"crossref","first-page":"11698","DOI":"10.1073\/pnas.1302634110","article-title":"Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo","volume":"110","author":"Beans","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.15.3.361","article-title":"Avermectins, new family of potent anthelmintic agents: producing organism and fermentation","volume":"15","author":"Burg","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1039\/b705652b","article-title":"Recent advances in the total synthesis of pharmaceutically relevant diterpenes","volume":"25","author":"Busch","year":"2008","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0055","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6308762","article-title":"Ivermectin: a potent new antiparasitic agent","volume":"221","author":"Campbell","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0060","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1021\/jm00184a014","article-title":"Ivermectin, a new broad-spectrum antiparasitic agent","volume":"23","author":"Chabala","year":"1980","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-0032-1317919","article-title":"Process development of Halaven\u00ae: synthesis of the C1\u2013C13 Fragment from d-(\u2212)-gulono-1,4-lactone","volume":"24","author":"Chase","year":"2013","journal-title":"Synlett"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1039\/b808331m","article-title":"Development of Yondelis\u00ae (trabectedin, ET-743). A semisynthetic process solves the supply problem","volume":"26","author":"Cuevas","year":"2009","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0075","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/ol0062502","article-title":"Synthesis of Ecteinascidin ET-743 and Phthalascidin Pt-650 from cyanosafracin B","volume":"2","author":"Cuevas","year":"2000","journal-title":"Org Lett"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0080","first-page":"155","article-title":"Farming sponges for the production of bioactive materials","volume":"44","author":"Duckworth","year":"1999","journal-title":"Mem Queensland Mus"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0085","series-title":"Sponge Sciences. Multidisciplinary Perspectives","first-page":"353","article-title":"The whys and whats of sponge chemistry: why chemists extract sponges and what problems does this cause?","author":"Dumdei","year":"1998"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0090","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-14-3252","article-title":"Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent","volume":"21","author":"Dybdal-Hargreaves","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0095","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/AAC.15.3.372","article-title":"Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component","volume":"15","author":"Egerton","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1074-5521(99)80128-8","article-title":"Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide \u03b1\u2032, \u03b2\u2032-epoxyketones","volume":"6","author":"Elofsson","year":"1999","journal-title":"Chem Biol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0105","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1021\/ja026216d","article-title":"Total synthesis of Ecteinascidin 743","volume":"124","author":"Endo","year":"2002","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1095-8339.1977.tb01163.x","article-title":"A comparative phvtochemical study of the diterpenes of some species of the genera Euphorbia and Elaeophorbia (Euphorbiaceae)","volume":"74","author":"Evans","year":"1977","journal-title":"Bot J Linn Soc"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1440-0960.1988.tb00383.x","article-title":"Home treatment of skin cancer and solar keratoses","volume":"29","author":"Green","year":"1988","journal-title":"Aust J Dermatol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM198507183130301","article-title":"Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis","volume":"313","author":"Greene","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0125","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1021\/ja993588m","article-title":"Crystal structure of epoxomicin: 20S proteasome reveals a molecular basis for selectivity of \u03b1\u2032, \u03b2\u2032-epoxyketone proteasome inhibitors","volume":"122","author":"Groll","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0130","doi-asserted-by":"crossref","first-page":"17532","DOI":"10.18632\/oncotarget.3947","article-title":"The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5","volume":"6","author":"Han","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0135","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.7164\/antibiotics.45.1746","article-title":"Epoxomicin, a new antitumor agent of microbial origin","volume":"45","author":"Hanada","year":"1992","journal-title":"J Antibiot"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0140","first-page":"247","article-title":"Plants used against cancer. A survey","volume":"32","author":"Hartwell","year":"1969","journal-title":"Lloydia"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0145","series-title":"Anticancer Agents from Natural Products","first-page":"215","article-title":"Ecteinascidin 743 (ET-743; Yondelis(TM)) Aplidin, and Kahalalide F","author":"Henriquez","year":"2005"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0150","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1351\/pac198658050701","article-title":"Halichondrins\u2014antitumor polyether macrolides from a marine sponge","volume":"58","author":"Hirata","year":"1986","journal-title":"Pure Appl Chem"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0155","series-title":"The isolation and structural characterization of the Ecteinascidins","author":"Holt","year":"1986"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0160","doi-asserted-by":"crossref","first-page":"10204","DOI":"10.1002\/chem.201402804","article-title":"Natural product synthesis at the interface of chemistry and biology","volume":"20","author":"Hong","year":"2014","journal-title":"Chem Eur J"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0165","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1126\/science.1241606","article-title":"14-Step synthesis of (+)-Ingenol from (+)-3-Carene","volume":"341","author":"J\u00f8rgensen","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0170","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1039\/c3np20126k","article-title":"From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes","volume":"30","author":"Kim","year":"2013","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-0028-1097982","article-title":"Occurrence of ingenol in Elaeophorbia species","volume":"26","author":"Kinghorn","year":"1974","journal-title":"Planta Med"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0180","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.2042-7158.1974.tb09305.x","article-title":"A quantitative gas\u2013liquid chromatographic method for phorbol and related diterpenes as their acetates","volume":"26","author":"Kinghorn","year":"1974","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JB.00826-07","article-title":"Characterization of the Saframycin A gene cluster from Streptomyces lavendulae NRRL 11002 revealing a nonribosomal peptide synthetase system for assembling the unusual tetrapeptidyl skeleton in an iterative manner","volume":"190","author":"Li","year":"2008","journal-title":"J Bacteriol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0190","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1055\/s-0032-1317415","article-title":"Semisynthesis of ingenol 3-angelate (PEP005): efficient stereoconservative angeloylation of alcohols","volume":"23","author":"Liang","year":"2012","journal-title":"Synlett"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0195","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nchembio.2007.1","article-title":"Modern synthetic efforts toward biologically active terpenes","volume":"3","author":"Maimone","year":"2007","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0200","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1021\/ja501881p","article-title":"Development of a concise synthesis of (+)-Ingenol","volume":"136","author":"McKerrall","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0205","doi-asserted-by":"crossref","first-page":"8859","DOI":"10.1021\/jo034547i","article-title":"Synthesis of natural ecteinascidins (ET-729, ET-745, ET-759B, ET-736, ET-637, ET-594) from Cyanosafracin B","volume":"68","author":"Menchaca","year":"2003","journal-title":"J Org Chem"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0210","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/med.21312","article-title":"Peptide-based proteasome inhibitors in anticancer drug design","volume":"34","author":"Micale","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0215","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/ar500424a","article-title":"Academia\u2013Industry symbiosis in organic chemistry","volume":"48","author":"Michaudel","year":"2015","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00227-003-1060-5","article-title":"Intracellular bacteria associated with the ascidian Ecteinascidia turbinata: phylogenic and in situ hybridization analysis","volume":"143","author":"Moss","year":"2003","journal-title":"Mar Biol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-1656(99)00052-8","article-title":"The discovery and development of marine compounds with pharmaceutical potential","volume":"70","author":"Munro","year":"1999","journal-title":"J Biotechnol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/34.2.195","article-title":"Ivermectin in human medicine","volume":"34","author":"Ottesen","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10482-007-9143-9","article-title":"Bacterial diversity associated with the Caribbean tunicate Ecteinascidia turbinata","volume":"92","author":"Perez-Matos","year":"2007","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0240","first-page":"633","article-title":"The sap from Euphorbia peplus is effective against human non-melanoma skin cancers","volume":"164","author":"Ramsay","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0245","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1021\/cb200244t","article-title":"Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743","volume":"6","author":"Rath","year":"2011","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0250","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1021\/jo00302a007","article-title":"Ecteinascidins 729, 743, 745, 759A, 759B and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata","volume":"55","author":"Rinehart","year":"1990","journal-title":"J Org Chem"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0255","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0031-9422(00)81076-6","article-title":"Biologically active diterpene esters from Euphorbia peplus","volume":"24","author":"Rizk","year":"1985","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0260","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/BF01976131","article-title":"Constituents of Egyptian Euphorbiaceae. IX. Irritant and cytotoxic ingenane esters from Euphorbia paralias L","volume":"36","author":"Sayed","year":"1980","journal-title":"Experientia"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0265","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1111\/1462-2920.12908","article-title":"Identification and analysis of the bacterial endosymbiont specialized for production of the chemotherapeutic natural product ET-743","volume":"17","author":"Schofield","year":"2015","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0270","series-title":"Food-Drugs from the Sea: Proceedings 1969","author":"Sigel","year":"1970"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0275","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0960-894X(99)00376-5","article-title":"Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology","volume":"9","author":"Sin","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0280","first-page":"161","article-title":"Development, pharmacokinetics and mode of action of ivermectin","volume":"59","author":"Sutherland","year":"1990","journal-title":"Acta Leiden"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.04.008","article-title":"Proteasome inhibitors","volume":"96","author":"Teicher","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0290","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3389\/fmicb.2015.00890","article-title":"Targeted metagenomics as a tool to tap into marine natural product diversity for the discovery and production of drug candidates","volume":"6","author":"Trindade","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0295","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2958.2004.04433.x","article-title":"Molecular characterization of the safracin biosynthetic pathway from Pseudomonas fluorescens A2-2: designing new cytotoxic compounds","volume":"56","author":"Velasco","year":"2005","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0300","doi-asserted-by":"crossref","first-page":"928","DOI":"10.5694\/j.1326-5377.1976.tb141173.x","article-title":"Home treatment of basal cell carcinoma","volume":"1","author":"Weedon","year":"1976","journal-title":"Med J Aust"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0305","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1021\/jo00302a006","article-title":"Antitumor tetrahydroisoquinoline alkaloids from the colonial ascidian Ecteinascidia turbinata","volume":"55","author":"Wright","year":"1990","journal-title":"J Org Chem"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0310","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2012.12.008","article-title":"Targeting HIV latency: pharmacologic strategies toward eradication","volume":"18","author":"Xing","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0315","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1039\/c3np70051h","article-title":"From micrograms to grams: scale-up synthesis of eribulin mesylate","volume":"30","author":"Yu","year":"2013","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.pharmthera.2015.12.002_bb0320","series-title":"Ann. Rept. Med. Chem","first-page":"227","article-title":"Case history: discovery of Eribulin (HalavenTM), a Halichondrin B analogue that prolongs overall survival in patients with metastatic breast cancer","volume":"Vol. 46","author":"Yu","year":"2011"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725815002284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725815002284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T20:52:25Z","timestamp":1653857545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725815002284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":64,"alternative-id":["S0163725815002284"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2015.12.002","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing natural product drugs: Supply problems and how they have been overcome","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2015.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}